JPS4925121A - - Google Patents

Info

Publication number
JPS4925121A
JPS4925121A JP47066301A JP6630172A JPS4925121A JP S4925121 A JPS4925121 A JP S4925121A JP 47066301 A JP47066301 A JP 47066301A JP 6630172 A JP6630172 A JP 6630172A JP S4925121 A JPS4925121 A JP S4925121A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47066301A
Other languages
Japanese (ja)
Other versions
JPS5512435B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP6630172A priority Critical patent/JPS5512435B2/ja
Priority to HUTA1257A priority patent/HU166029B/hu
Priority to FR7320833A priority patent/FR2190414B1/fr
Priority to NL7308048A priority patent/NL7308048A/xx
Priority to US371528A priority patent/US3925357A/en
Priority to CS4540A priority patent/CS168036B2/cs
Priority to BE132836A priority patent/BE801588A/xx
Priority to SE7309138A priority patent/SE402916B/xx
Priority to DE2332840A priority patent/DE2332840A1/de
Priority to CH955873A priority patent/CH573435A5/xx
Priority to CA175,329A priority patent/CA996548A/en
Priority to AT576473A priority patent/AT325206B/de
Priority to PL1973163783A priority patent/PL92969B1/pl
Priority to AU57600/73A priority patent/AU469986B2/en
Priority to GB3147473A priority patent/GB1386566A/en
Publication of JPS4925121A publication Critical patent/JPS4925121A/ja
Publication of JPS5512435B2 publication Critical patent/JPS5512435B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP6630172A 1972-07-01 1972-07-01 Expired JPS5512435B2 (enExample)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (enExample) 1972-07-01 1972-07-01
HUTA1257A HU166029B (enExample) 1972-07-01 1973-06-01
FR7320833A FR2190414B1 (enExample) 1972-07-01 1973-06-07
NL7308048A NL7308048A (enExample) 1972-07-01 1973-06-08
US371528A US3925357A (en) 1972-07-01 1973-06-19 ' -sulfobenzylpenicillin salt
CS4540A CS168036B2 (enExample) 1972-07-01 1973-06-25
BE132836A BE801588A (fr) 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline
SE7309138A SE402916B (sv) 1972-07-01 1973-06-28 Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter
DE2332840A DE2332840A1 (de) 1972-07-01 1973-06-28 Alpha-sulfobenzylpenicillindiaminsalze und verfahren zu ihrer herstellung
CH955873A CH573435A5 (enExample) 1972-07-01 1973-06-29
CA175,329A CA996548A (en) 1972-07-01 1973-06-29 .alpha.-SULFOBENZYLPENICILLIN SALT
AT576473A AT325206B (de) 1972-07-01 1973-06-29 Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen
PL1973163783A PL92969B1 (enExample) 1972-07-01 1973-07-02
AU57600/73A AU469986B2 (en) 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts
GB3147473A GB1386566A (en) 1972-07-01 1973-07-02 Alpha-sulphobenzyl penicillin salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (enExample) 1972-07-01 1972-07-01

Publications (2)

Publication Number Publication Date
JPS4925121A true JPS4925121A (enExample) 1974-03-06
JPS5512435B2 JPS5512435B2 (enExample) 1980-04-02

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6630172A Expired JPS5512435B2 (enExample) 1972-07-01 1972-07-01

Country Status (15)

Country Link
US (1) US3925357A (enExample)
JP (1) JPS5512435B2 (enExample)
AT (1) AT325206B (enExample)
AU (1) AU469986B2 (enExample)
BE (1) BE801588A (enExample)
CA (1) CA996548A (enExample)
CH (1) CH573435A5 (enExample)
CS (1) CS168036B2 (enExample)
DE (1) DE2332840A1 (enExample)
FR (1) FR2190414B1 (enExample)
GB (1) GB1386566A (enExample)
HU (1) HU166029B (enExample)
NL (1) NL7308048A (enExample)
PL (1) PL92969B1 (enExample)
SE (1) SE402916B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (enExample) * 1978-07-29 1980-02-13

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007485B1 (ru) * 2001-02-24 2006-10-27 Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг Производные ксантина, способ их получения, фармацевтическая композиция на их основе и способ ее получения
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
EP3542801A1 (en) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) * 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
CN103816158A (zh) * 2008-08-15 2014-05-28 勃林格殷格翰国际有限公司 用于治疗fab-相关疾病的嘌呤衍生物
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
KR20200028498A (ko) 2010-06-24 2020-03-16 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
HUE061596T2 (hu) 2011-07-15 2023-07-28 Boehringer Ingelheim Int Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (enExample) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (enExample) * 1978-07-29 1980-02-13

Also Published As

Publication number Publication date
US3925357A (en) 1975-12-09
NL7308048A (enExample) 1974-01-03
CS168036B2 (enExample) 1976-05-28
BE801588A (fr) 1973-12-28
JPS5512435B2 (enExample) 1980-04-02
AU469986B2 (en) 1976-02-26
FR2190414A1 (enExample) 1974-02-01
FR2190414B1 (enExample) 1976-07-02
CA996548A (en) 1976-09-07
PL92969B1 (enExample) 1977-04-30
AU5760073A (en) 1975-01-09
HU166029B (enExample) 1974-12-28
AT325206B (de) 1975-10-10
SE402916B (sv) 1978-07-24
GB1386566A (en) 1975-03-12
CH573435A5 (enExample) 1976-03-15
DE2332840A1 (de) 1974-01-17

Similar Documents

Publication Publication Date Title
CH584293A5 (enExample)
CH584961A5 (enExample)
BG17907A1 (enExample)
BG18370A1 (enExample)
BG18378A1 (enExample)
BG18663A1 (enExample)
BG18669A1 (enExample)
BG19753A1 (enExample)
BG26628A1 (enExample)
CH123172A4 (enExample)
CH1285173A4 (enExample)
CH4872A4 (enExample)
CH545548A (enExample)
CH559105A5 (enExample)
CH559112A5 (enExample)
CH559391A5 (enExample)
CH559798B5 (enExample)
CH560126A5 (enExample)
CH561861A5 (enExample)
CH563142A5 (enExample)
CH566531A5 (enExample)
CH566821A5 (enExample)
CH567666A5 (enExample)
CH569336A5 (enExample)
CH569691A5 (enExample)